Edentulous in the molar area of the mandible.
Conditions
Interventions
Intervention 1: Intervention group: Lidocaine, Name of the substance used: Persocaine E, Chemical composition per ml: Lidocaine hydrochloride 20 mg and epinephrine 12.5 micrograms, Dosage: 3.6 mg (two
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Patients who require implant treatment in this area due to the loss of mandibular molar teeth. Patients with systemic conditions ASA class one and two. Patients aged 18-60 years non-smoking patients The implant placement area should have healed and there should be no need for bone reconstruction. At least 3 months must have passed since the extraction treatment. There should be no unusual presence in the graphical representation of the Lucency or opacity region.
Exclusion criteria
Exclusion criteria: Prohibition of the use of epinephrine with a preservative The use of narcotics, sedatives, NSAIDs, psychoactive substances, and anything that alters the patient's perception of pain. Advanced surgical needs Non-healthiness of the pulp of the adjacent teeth Need for remote flap Patients who are unwilling to sign the consent form. The patient expresses pain during soft tissue manipulation and requires the injection of more than two carpules of anaesthetic. Prolongation of the surgical process (more than 1 hour)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain intensity score. Timepoint: 1 and 4 hours after the surgery is completed. Method of measurement: Visual Analogue Scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZohreh Afshari
Esfahan University of Medical Sciences
Outcome results
None listed